Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Doximity (DOCS) Cash & Equivalents (2021 - 2025)

Doximity (DOCS) has disclosed Cash & Equivalents for 5 consecutive years, with $64.8 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 60.77% to $64.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $64.8 million through Dec 2025, down 60.77% year-over-year, with the annual reading at $209.6 million for FY2025, 116.58% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $64.8 million at Doximity, down from $169.2 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $594.3 million in Q2 2021, with the low at $64.8 million in Q4 2025.
  • Average Cash & Equivalents over 5 years is $154.7 million, with a median of $117.9 million recorded in 2022.
  • The sharpest move saw Cash & Equivalents plummeted 81.48% in 2022, then surged 178.61% in 2023.
  • Over 5 years, Cash & Equivalents stood at $85.1 million in 2021, then skyrocketed by 60.39% to $136.5 million in 2022, then decreased by 9.79% to $123.1 million in 2023, then soared by 34.27% to $165.3 million in 2024, then crashed by 60.77% to $64.8 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $64.8 million, $169.2 million, and $137.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.